Study #2020-0728
Phase II Study of AG-120 in IDH1 Mutant Chondrosarcoma
MD Anderson Study Status
Not Accepting
Treatment Agent
AG-120
Description
This study is being done to see whether AG-120 is an effective and safe treatment for people with advanced/metastatic or recurrent chondrosarcoma that has IDH1 mutation.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Chondrosarcoma, Chondrosarcoma, Grade 2, Chondrosarcoma, Grade 3, IDH1 Gene Mutation
Study phase:
Phase II
Physician name:
Anthony Conley
Department:
Sarcoma Medical Oncology
For general questions about clinical trials:
1-844-227-7897
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.